Nanobiotix - Stock

Nanobiotix P/E 2024

Nanobiotix P/E

-6.72

Ticker

NANO.PA

ISIN

FR0011341205

WKN

A1J7EB

As of Jun 22, 2024, Nanobiotix's P/E ratio was -6.72, a 48.34% change from the -4.53 P/E ratio recorded in the previous year.

The Nanobiotix P/E history

Nanobiotix Aktienanalyse

What does Nanobiotix do?

Nanobiotix SA is a biotechnology company specializing in the development of nanoparticles used in cancer therapy to increase the effectiveness of radiation therapy. It was founded in 2003 in Paris, France by Dr. Laurent Lévy and his team. The company went public in 2012 and is currently listed on the Euronext Paris exchange. Nanobiotix's business model is based on the production and marketing of nanoparticles called NBTXR3, which enhance the effectiveness of radiation therapy. The company works with various partners to further develop its technology and explore new applications. Nanobiotix has two main divisions: one focused on developing nanoparticles to enhance radiation therapy for cancer, and another dedicated to using nanoparticles as drug carriers. Its flagship product, NBTXR3, is designed specifically for cancer therapy and has shown promising results. Nanobiotix is also working on combining NBTXR3 with immunotherapies to further improve cancer treatment. In summary, Nanobiotix is an innovative company specializing in the development of nanoparticles to enhance radiation therapy for cancer and improve patient treatment. Nanobiotix ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Nanobiotix's P/E Ratio

The Price to Earnings (P/E) Ratio of Nanobiotix is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Nanobiotix's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Nanobiotix is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Nanobiotix’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Nanobiotix Stock

What is the price-to-earnings ratio of Nanobiotix?

The price-earnings ratio of Nanobiotix is currently -6.72.

How has the price-earnings ratio of Nanobiotix changed compared to last year?

The price-to-earnings ratio of Nanobiotix has increased by 48.34% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Nanobiotix high compared to other companies?

Yes, the price-to-earnings ratio of Nanobiotix is high compared to other companies.

How does an increase in the price-earnings ratio of Nanobiotix affect the company?

An increase in the price-earnings ratio of Nanobiotix would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Nanobiotix affect the company?

A decrease in the price-earnings ratio of Nanobiotix would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Nanobiotix?

Some factors that influence the price-earnings ratio of Nanobiotix are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Nanobiotix pay?

Over the past 12 months, Nanobiotix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanobiotix is expected to pay a dividend of 0 EUR.

What is the dividend yield of Nanobiotix?

The current dividend yield of Nanobiotix is .

When does Nanobiotix pay dividends?

Nanobiotix pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nanobiotix?

Nanobiotix paid dividends every year for the past 0 years.

What is the dividend of Nanobiotix?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nanobiotix located?

Nanobiotix is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nanobiotix kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nanobiotix from 6/22/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/22/2024.

When did Nanobiotix pay the last dividend?

The last dividend was paid out on 6/22/2024.

What was the dividend of Nanobiotix in the year 2023?

In the year 2023, Nanobiotix distributed 0 EUR as dividends.

In which currency does Nanobiotix pay out the dividend?

The dividends of Nanobiotix are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Nanobiotix stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Nanobiotix

Our stock analysis for Nanobiotix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanobiotix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.